scispace - formally typeset
C

Cuicui Liu

Researcher at Peking Union Medical College

Publications -  14
Citations -  276

Cuicui Liu is an academic researcher from Peking Union Medical College. The author has contributed to research in topics: Induced pluripotent stem cell & Haematopoiesis. The author has an hindex of 6, co-authored 14 publications receiving 136 citations.

Papers
More filters
Journal ArticleDOI

Decoding Human Megakaryocyte Development.

TL;DR: Single-cell RNA sequencing of human MKs from embryonic yolk sac and fetal liver is used to characterize the transcriptome, cellular heterogeneity, and developmental trajectories of early megakaryopoiesis and identifies a subpopulation of CD42b+CD14+ MKs in vivo that exhibit high expression of genes associated with immune responses.
Journal ArticleDOI

MSX2 Initiates and Accelerates Mesenchymal Stem/Stromal Cell Specification of hPSCs by Regulating TWIST1 and PRAME

TL;DR: A critical role of muscle segment homeobox 2 (MSX2) is identified in initiating and accelerating the molecular program that leads to mesenchymal stem/stromal cell (MSC) differentiation from hPSCs.
Journal ArticleDOI

MEIS1 Regulates Hemogenic Endothelial Generation, Megakaryopoiesis, and Thrombopoiesis in Human Pluripotent Stem Cells by Targeting TAL1 and FLI1.

TL;DR: Myeloid ectopic viral integration site 1 homolog (MEIS1) is identified as a crucial regulator of hPSC early hematopoietic differentiation and can be potentially manipulated for large-scale generation of HPCs or platelets from hPSCs for therapeutic applications in regenerative medicine.
Journal ArticleDOI

Integrated Biophysical and Biochemical Signals Augment Megakaryopoiesis and Thrombopoiesis in a Three-Dimensional Rotary Culture System

TL;DR: It is found that a rotary cell culture system (RCCS) can potentiate megakaryopoiesis and significantly improve the efficiency of platelet generation, an important step toward large‐scale platelet production for future biomedical and clinical applications.
Journal ArticleDOI

Thrombopoietin knock-in augments platelet generation from human embryonic stem cells.

TL;DR: The results demonstrate that autonomous production of cytokines in hESCs may become a powerful approach for cost-effective and large-scale platelet generation in translational medicine.